Nuklover sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-08-01
Share capital
5,000.00 PLN
Average employment (people)
1 (2025)
Activity description

Nuklover is a company that supports nuclear medicine and radiopharmacy by providing products such as germanium-gallium generators, radiopharmaceutical synthesis modules, and quality control equipment for radiopharmaceuticals. They also offer isotopes like 161-terbium and oxygen-18 enriched water, along with filtration systems for nuclear medicine.

Registered address
ul. Franciszka Klimczaka 1, 02-797 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-52342-93167-EEIEC-19

Financials

From the notes

Profit allocationNo decision

Filing timeliness

The financial statement for 2025 was filed on time.

  • 202510/06/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 92%
Division · Retail trade6,909 / 9,987
Top 69%
City · Warszawa28,754 / 56,729
Top 51%
Voivodeship · Mazowieckie40,137 / 76,892
Top 52%
Country · Poland159,440 / 297,069
Top 54%

Results vs industry

Revenue
This companyUSD 227.48kMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD 119.92kMedianUSD 21.16kAverageUSD 85.84k
Operating costs
This companyUSD 91.62kMedianUSD 1.88mAverageUSD 5.06m
Assets
This companyUSD 173.31kMedianUSD 545.50kAverageUSD 1.76m

Offer

  • Germanium-gallium generators
  • Radiopharmaceutical synthesis modules
  • Radiopharmaceutical quality control equipment
  • Terbium-161 isotope
  • Oxygen-18 enriched water
  • Nuclear medicine filtration systems

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Analytics

Authorized Representatives

Magdalena Ałła Brzezowska age 47 – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
45$1,215.5690%
5$135.0610%

Magdalena Ałła Brzezowska and Jan Franciszek Brzezowski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2024-09-24.

  • mBank
    17 1140 2004 0000 3103 0106 2109
  • mBank
    27 1140 2004 0000 3612 2382 4236
  • mBank
    14 1140 2004 0000 3502 8510 8377

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Nucmed sp. z o.o.
Kunctrade sp. z o.o.
Hemab Polska sp. z o.o.
Irimed sp. z o.o. sp. k.
Paramedica Polska sp. z o.o.
Medcell sp. z o.o.
Polrentgen sp. z o.o.
Sprzęt Laboratoryjny I Medyczny Labpartner Kbs sp. z o.o.
Alab-Med sp. z o.o.
Aveus Instruments sp. z o.o.

FAQ

Last updated: 2026-07-21